The results of phase - I of Oxford COVID-19 vaccine trial was published on Monday. Richard Borton, the editor-in-chief of UK-Based medical journal The Lancet, said, "it is safe, well-tolerated and immunogenic." He added that results are extremely encouraging.

#Oxford #COVID-19Vaccine #COVID-19VaccinePhase-I

Link: https://www.latestly.com/

Subscribe: https://www.youtube.com/c/LatestLYIndia
Facebook: https://www.facebook.com/latestly/
Twitter: https://twitter.com/latestly
Instagram: https://www.instagram.com/latestly